Nasonex tv commercials
TV spots
TV commercials Nasonex
The Nasonex Super Bowl 2023 TV Spot titled 'Cologne' was an advertisement that featured a man getting dressed in his apartment, spraying himself with cologne and then walking past a beehive. As he walked by, the bees flew out of the hive and began to follow him, ultimately chasing him down the stree...
The Nasonex TV Commercial for Seasonal Allergies featuring the Nasonex Bee has quickly become a household favorite. In the commercial, the Nasonex Bee is seen buzzing around a field of flowers, highlighting the beauty of nature while also bringing attention to the issue of seasonal allergies.As the...
The Nasonex TV spot, titled 'Celebrate Normal,' brings a fresh and innovative perspective on everyday life and the joy of experiencing the ordinary. This commercial beautifully captures the essence of celebrating the small moments that make life truly extraordinary.As the commercial begins, we are i...
Agenices
Agencies worked with Nasonex
McCann Worldgroup
McCann Worldgroup is a global advertising and marketing communications company headquartered in New York City. The company was founded in 1930 by Marion Harper Jr. and has since grown to become one of the world's largest marketing and advertising agency networks.McCann Worldgroup offers a wide range of marketing and advertising services, including brand strategy, creative development, media planning and buying, digital marketing, public relations...
Actors
Actors who starred in Nasonex commercials
What kind of company is Nasonex?
Company Profile: Nasonex
Nasonex is a brand name for mometasone, a synthetic corticosteroid. Nasonex nasal spray is used to treat allergy symptoms such as sneezing, congestion, and a runny nose caused by indoor and outdoor allergens. It is also used to treat nasal polyps in adults.
Nasonex is manufactured by Merck & Co., a multinational pharmaceutical company. The brand is distributed in the United States by Merck Sharp & Dohme Corp, a subsidiary of Merck & Co. Nasonex is also available in other countries under different names.
Nasonex was first approved by the United States Food and Drug Administration (FDA) in 1997 for the treatment of seasonal and perennial allergic rhinitis in adults and children six years and older. Later, it got approved for the treatment of nasal polyps in adults.
Products
Nasonex's main product is the mometasone nasal spray, which is available only through prescription. The nasal spray comes in two strengths, 50 mcg and 100 mcg, and is indicated for the treatment of seasonal and perennial allergic rhinitis and nasal polyps.
Company History
Merck & Co. began developing mometasone nasal spray in the 1980s and received FDA approval in 1997. Merck Sharp & Dohme began distributing Nasonex in the United States in 2001.
In 2007, Merck and Schering-Plough announced a joint venture in which Merck would acquire Schering-Plough. The merger was completed in 2009, and Nasonex became a Merck product.
Conclusion
Nasonex is a prescription nasal spray used for treating allergy symptoms and nasal polyps. The brand is owned by Merck & Co. and distributed in the United States by Merck Sharp & Dohme Corp. Nasonex is a well-established product in the allergy medication market, enjoying significant popularity among physicians and patients alike.
